{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:11:46Z","timestamp":1792699906196,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.autrev.2008.07.002","type":"journal-article","created":{"date-parts":[[2008,8,13]],"date-time":"2008-08-13T17:42:15Z","timestamp":1218649335000},"page":"62-68","source":"Crossref","is-referenced-by-count":36,"title":["Treatment of Raynaud's phenomenon"],"prefix":"10.1016","volume":"8","author":[{"given":"Mario","family":"Garc\u00eda-Carrasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Jim\u00e9nez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo O.","family":"Esc\u00e1rcega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mendoza-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Pardo-Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Galarza","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo P\u00e9rez","family":"Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2008.07.002_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMcp013013","article-title":"Clinical practice: Raynaud's phenomenon","volume":"347","author":"Wigley","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2008.07.002_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/rheumatology\/keh552","article-title":"Pathogenesis of Raynaud's phenomenon","volume":"44","author":"Herrick","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2008.07.002_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.autrev.2004.07.013","article-title":"Epidemiology of systemic sclerosis and Raynaud's phenomenon (Part A)","volume":"3","author":"Czirj\u00e1k","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2008.07.002_bib4","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.autrev.2004.07.014","article-title":"Epidemiology of systemic sclerosis and Raynaud's phenomenon (Part B)","volume":"3","author":"Czirj\u00e1k","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2008.07.002_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2006.03.004","article-title":"Undifferentiated connective tissue diseases (UCTD)","volume":"6","author":"Mosca","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2008.07.002_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-857X(03)00019-X","article-title":"Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma","volume":"29","author":"Hummers","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2008.07.002_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2006.12.006","article-title":"Vascular complications of scleroderma","volume":"6","author":"Guiducci","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2008.07.002_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.rdc.2005.04.006","article-title":"Raynaud's phenomenon in mixed connective tissue disease","volume":"31","author":"Grader-Beck","year":"2005","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2008.07.002_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0026-2862(03)00018-9","article-title":"Comparision of thermogaphy and laser Doppler imaging in the assessment of Raynaud's phenomenon","volume":"66","author":"Clark","year":"2003","journal-title":"Microvasc Res"},{"key":"10.1016\/j.autrev.2008.07.002_bib10","first-page":"322","article-title":"El tratamiento del fen\u00f3meno de Raynaud","volume":"27","author":"Garc\u00eda-Carrasco","year":"2000","journal-title":"Rev Esp Reumatol"},{"key":"10.1016\/j.autrev.2008.07.002_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11926-002-0007-z","article-title":"Raynaud's phenomenon: epidemiology and risk factors","volume":"4","author":"Fraenkel","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2008.07.002_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0002-9149(98)00708-5","article-title":"Effect of long-term estrogen therapy on brachial arterial endothelium-dependent vasodilation in women with Raynaud's phenomenon secondary to systemic sclerosis","volume":"82","author":"Lekakis","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2008.07.002_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0895-4356(99)00005-0","article-title":"Association between cigarette and alcohol consumption and Raynaud's phenomenon","volume":"52","author":"Palesch","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.autrev.2008.07.002_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0002-9343(89)90261-1","article-title":"Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study","volume":"86","author":"DiGiacomo","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2008.07.002_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2796.1997.91105000.x","article-title":"Treatment of primary Raynaud's syndrome with traditional Chinese acupuncture","volume":"241","author":"Appiah","year":"1997","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.autrev.2008.07.002_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0197-2456(98)00046-4","article-title":"Behavioral and pharmacologic interventions: the Raynaud's treatment study","volume":"20","author":"Thompson","year":"1999","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.autrev.2008.07.002_bib17","article-title":"Raynaud's disease \u2014 drug therapy","volume":"vol. 111","author":"Schifris","year":"2002"},{"key":"10.1016\/j.autrev.2008.07.002_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/jaut.2000.0456","article-title":"Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production","volume":"16","author":"Stosic-Grujicic","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2008.07.002_bib19","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","article-title":"Calcium channel blockers for Raynaud's phenomenon in systemic sclerosis","volume":"44","author":"Thompson","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.002_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/rheumatology\/keh390","article-title":"Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis","volume":"44","author":"Thompson","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2008.07.002_bib21","doi-asserted-by":"crossref","first-page":"6F","DOI":"10.1016\/0002-9149(92)90182-X","article-title":"Molecular and cellular aspects of calcium channel antagonism","volume":"70","author":"Schwartz","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.autrev.2008.07.002_bib22","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.autrev.2008.07.002_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/pcad.2000.7010","article-title":"Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies","volume":"43","author":"Opie","year":"2000","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"10.1016\/j.autrev.2008.07.002_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archinte.160.8.1101","article-title":"Comparison of sustained release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon: results from a randomized clinical trial with 1-year follow-up","volume":"160","author":"Wigley","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2008.07.002_bib25","first-page":"H698","article-title":"Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation","volume":"260","author":"Dinnerman","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.autrev.2008.07.002_bib26","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO;2-S","article-title":"Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma","volume":"43","author":"Flavahan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2008.07.002_bib27","first-page":"CD000956","article-title":"Prazosin for Raynaud's phenomenon in progressive systemic sclerosis","volume":"2","author":"Pope","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.autrev.2008.07.002_bib28","first-page":"S692","article-title":"Multi-center, blinded, randomized, placebo-controlled study of OPC-28326, a selective alpha-adrenergic antagonist, in patients with Raynaud's phenomenon","volume":"9","author":"Wigley","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2008.07.002_bib29","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1345\/aph.1H201","article-title":"Renin\u2013angiotensin system mediators and Raynaud's phenomenon","volume":"40","author":"Wood","year":"2006","journal-title":"Ann Pharmacother"},{"issue":"12","key":"10.1016\/j.autrev.2008.07.002_bib30","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T","article-title":"Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial","volume":"42","author":"Dziadzio","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.002_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archinte.166.2.231","article-title":"Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud disease","volume":"166","author":"Caglayan","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2008.07.002_bib32","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","article-title":"Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy","volume":"112","author":"Fries","year":"2005","journal-title":"Circulation"},{"issue":"9191","key":"10.1016\/j.autrev.2008.07.002_bib33","doi-asserted-by":"crossref","first-page":"p1670","DOI":"10.1016\/S0140-6736(99)04095-7","article-title":"Effect of nitric-oxide-generating system on microcirculatory blood flow in skin of patients with severe Raynaud's syndrome: a randomised trial","volume":"354","author":"Tucker","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autrev.2008.07.002_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/rheumatology\/keg480","article-title":"Safety and efficacy of iloprost for the treatment of ischaemic digits in pediatric connective tissue diseases","volume":"43","author":"Zulian","year":"2004","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.autrev.2008.07.002_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-120-3-199402010-00004","article-title":"Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study","volume":"120","author":"Wigley","year":"1994","journal-title":"Ann Int Med"},{"key":"10.1016\/j.autrev.2008.07.002_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1191\/1358863x05vm639ra","article-title":"Mechanisms of Raynaud's disease","volume":"10","author":"Cookea","year":"2005","journal-title":"Vasc Med"},{"issue":"4","key":"10.1016\/j.autrev.2008.07.002_bib37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/rheumatology\/ken001","article-title":"Long-term experience of bosentan for treating ulcers and healed ulcers in systemic sclerosis patients","volume":"47","author":"Garcia de la Pena-Lefebvre","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2008.07.002_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/micr.1013","article-title":"Surgery for ischemic pain and Raynaud's phenomenon in scleroderma: a description of treatment protocol and evaluation of results","volume":"21","author":"Tomaino","year":"2001","journal-title":"Microsurgery"},{"key":"10.1016\/j.autrev.2008.07.002_bib39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00000542-200501000-00032","article-title":"Successful use of spinal cord stimulation in the treatment of severe Raynaud's disease of the hand","volume":"102","author":"Sibell","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.autrev.2008.07.002_bib40","first-page":"102","article-title":"Ulnar artery involvement in systemic sclerosis (scleroderma)","volume":"29","author":"Taylor","year":"2002","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208001146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997208001146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T05:56:27Z","timestamp":1557726987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997208001146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1568997208001146"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2008.07.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}